retatrutide ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Company linked to raid on

Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts. Such practices not only help prevent excess weight gain but can also lead to numerous health benefits that go beyond weight control, he concludes

Am J Epidemiol 2003;157:456-66

This combination delivers protein from two sources and tastes like a meal in miniature

The decision to start, continue or stop a GLP-1 is highly individual and best made with a multidisciplinary team familiar with GLP-1 and eating disorders

Overall, the presented cumulative evidence supports the benefits of GLP-1RA plus SGLT2i combination therapy on metabolic-cardiovascular-renal disease in patients with T2DM, with a low hypoglycemia risk